Development Of Priority Vaccines For Disease-Endemic Countries: Risk And Benefit
| Autor: | Julie Milstien, Richard A. Cash, Daniel Wikler, John Wecker |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Vaccines
Economic growth medicine.medical_specialty Endemic Diseases Cost–benefit analysis Public economics Health Policy Public health Developing country Action plan Economics medicine Humans Immunization Product (category theory) Policy Making Risk assessment Developing Countries Developed country Health policy |
| Zdroj: | Health Affairs. 24:718-728 |
| ISSN: | 1544-5208 0278-2715 |
| Popis: | Decisions regarding vaccine regulation and use made by institutions in industrialized countries can have an unintended impact on vaccines' availability in disease-endemic countries. However, regulatory and programmatic decision making by such countries, taking into consideration local risks and benefits, requires adequate resources, both human and financial. Such differing risk-benefit determinations between industrialized and disease-endemic countries will increase product divergence. We propose a single universal standard for risk assessment, based on maximizing net benefit, and an action plan to improve access to priority vaccines through a more robust determination of risk and benefit. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|